ASX Announcement MAYNE PHARMA BIOSHARES SUMMIT PRESENTATION 5 August 2026, Adelaide, Australia: Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), today provides the presentation to be given by the Company’s CEO Mr Aaron Gray to...
Mayne Pharma Bioshares Summit Presentation
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Earlier from Mayne Pharma
- Notification of cessation of securities - MYX
- Notification regarding unquoted securities - MYX
- Non-Executive Director appointment
- Mayne Pharma to present at the 20th Bioshares Summit
- Mayne Pharma reports unaudited Q4 and FY26 results
Later from Mayne Pharma
- Initial Director's Interest Notice
- Mayne Pharma launches Investor Hub
- Upcoming presentation of Imvexxy clinical data
- Notification of date for release of FY26 results
- 2026 Corporate Governance Statement and Appendix 4G
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma